Interferon

Results: 1306



#Item
41Keir, M.E., Butte, M.J., Freeman, G.J., and Sharpe, A.HAnnu. Rev. Immunol. 26, 677–704. Larkin, J., Chiarion-Sileni, V., Gonzalez, R., Grob, J.J., Cowey, C.L., Lao, C.D., Schadendorf, D., Dummer, R., Smylie,

Keir, M.E., Butte, M.J., Freeman, G.J., and Sharpe, A.HAnnu. Rev. Immunol. 26, 677–704. Larkin, J., Chiarion-Sileni, V., Gonzalez, R., Grob, J.J., Cowey, C.L., Lao, C.D., Schadendorf, D., Dummer, R., Smylie,

Add to Reading List

Source URL: www.microfluidics.ethz.ch

Language: English - Date: 2015-12-17 08:31:39
4244 Genome Informatics 16(1): 44–Antiviral Activity of Oligomerization-Deficient Stat1 Uwe Vinkemeier

44 Genome Informatics 16(1): 44–Antiviral Activity of Oligomerization-Deficient Stat1 Uwe Vinkemeier

Add to Reading List

Source URL: www.jsbi.org

Language: English - Date: 2005-12-28 10:55:28
43ACTIMMUNE ® (Interferon gamma-1b) DESCRIPTION ACTIMMUNE® (Interferon gamma-1b), a biologic ­ response modifier, is a single-chain polypeptide containing 140 amino acids. Production of

ACTIMMUNE ® (Interferon gamma-1b) DESCRIPTION ACTIMMUNE® (Interferon gamma-1b), a biologic ­ response modifier, is a single-chain polypeptide containing 140 amino acids. Production of

Add to Reading List

Source URL: www.compassforpatients.com

Language: English - Date: 2016-01-13 11:38:39
    441 TITLE PAGE Treatment as prevention: The breaking of taboos is required in the fight against hepatitis C among people who inject drugs Author: Philip Bruggmann

    1 TITLE PAGE Treatment as prevention: The breaking of taboos is required in the fight against hepatitis C among people who inject drugs Author: Philip Bruggmann

    Add to Reading List

    Source URL: www.hepatitis-c-initiative.eu

    Language: English - Date: 2013-06-13 03:09:16
    45Adaptivt immunrespons og Pseudomonas aeruginonas biofilm

    Adaptivt immunrespons og Pseudomonas aeruginonas biofilm

    Add to Reading List

    Source URL: dskm.dk

    Language: English - Date: 2014-01-15 12:04:28
    46  www.impactaging.com AGING, May 2015, Vol. 7, No 5 Editorial  

      www.impactaging.com AGING, May 2015, Vol. 7, No 5 Editorial  

    Add to Reading List

    Source URL: www.impactaging.com

    Language: English
    47NIH Public Access Author Manuscript J Hepatol. Author manuscript; available in PMC 2012 July 1. NIH-PA Author Manuscript

    NIH Public Access Author Manuscript J Hepatol. Author manuscript; available in PMC 2012 July 1. NIH-PA Author Manuscript

    Add to Reading List

    Source URL: www.hepatitis-c-initiative.eu

    Language: English - Date: 2013-03-13 13:51:00
    48UPDATEDEuropean Monitoring Centre for Drugs and Drug Addiction PERSPECTIVES ON DRUGS

    UPDATEDEuropean Monitoring Centre for Drugs and Drug Addiction PERSPECTIVES ON DRUGS

    Add to Reading List

    Source URL: www.hepatitis-c-initiative.eu

    Language: English - Date: 2013-10-28 09:43:04
    49Donate Side effects Interferon and ribavirin are very strong drugs and both have potential side effects. Not everyone experiences these side effects, but it is rare for someone to have none at all. You should expect to

    Donate Side effects Interferon and ribavirin are very strong drugs and both have potential side effects. Not everyone experiences these side effects, but it is rare for someone to have none at all. You should expect to

    Add to Reading List

    Source URL: www.hepatitis-c-initiative.eu

    Language: English - Date: 2014-06-13 03:57:36
    50SUPPLEMENT ARTICLE Guidelines for the Treatment of Hepatitis C Virus Infection in Injection Drug Users: Status Quo in the European Union Countries Jens Reimer,1 Bernd Schulte,1 Xavier Castells,3 Ingo Schafer,1 Susanne P

    SUPPLEMENT ARTICLE Guidelines for the Treatment of Hepatitis C Virus Infection in Injection Drug Users: Status Quo in the European Union Countries Jens Reimer,1 Bernd Schulte,1 Xavier Castells,3 Ingo Schafer,1 Susanne P

    Add to Reading List

    Source URL: www.hepatitis-c-initiative.eu

    Language: English - Date: 2014-06-10 04:21:20